BSG-001

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBSG-001
Drug Alias NameBSG-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsToll-like receptor modulators
TargetsNot applicable
Therapy Area/IndicationsAscitesPleural Effusion, Malignant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiosyngen Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiosyngen Pte Ltd
Inactive CompaniesN/A
Active IndicationsAscitesPleural Effusion, Malignant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A